IBIO — iBio Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for iBio, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2020 June 30th	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-16.4	-23.2	-50.3	-65	-24.9
Depreciation
Amortisation
Non-Cash Items	0.388	1.89	5.79	22.4	8.27
Unusual Items
Other Non-Cash Items
Changes in Working Capital	0.47	-11.2	3.24	10.8	-3.17
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities	-13.3	-30.1	-37.5	-30.4	-18.6
Capital Expenditures	-1.15	-5.16	-11.6	-6.43	-0.21
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	—	-21.3	6.5	13.4	1.12
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-1.15	-26.5	-5.13	7.01	0.906
Financing Cash Flow Items	-2.17	0.836	-0.372	-0.061	0.109
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	65.2	78.8	-6.13	2.3	24.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	50.7	22.3	-48.7	-21.1	6.85